Human Erythrocyte Phosphoribosylpyrophosphate Content and “Generation” During a Constant Rate Infusion of Xylitol

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 41)


Marked increases in serum uric acid concentrations have been observed following rapid intravenous infusions of fructose (2,6). With constant rate intravenous infusions of 0.5 g fructose/kg body weight/hr over 5 hours however we cannot demonstrate remarkable changes in serum uric acid levels (3,4). With the same dose xylitol, with a rate of 0.5 g xylitol/kg body weight/hr, we are able to demonstrate even higher increases in serum uric acid concentrations than with 1.5 g fructose/kg body weight/hr over 5 hours (3,4). This hyperuricemic effect of xylitol could be due in part- comparable to that of fructose- to an increased rate of purine synthesis de novo or an accelerated degradation of purine ribonucleotides. Since intracellular 5-phosphoribosyl-1-pyrophosphate (PRPP) concentration limits purine biosynthesis de novo and is also a substrate in the reutilization pathways for purine bases we assessed PRPP levels and PRPP “generation” in erythrocytes after oral administration and during constant rate infusion of varying xylitol doses.


Serum Uric Acid Serum Uric Acid Level Infusion Period Purine Nucleotide Constant Rate Infusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bode, Ch., Schumacher, H., Goebell, H., Zelder, O. and Pelzelj H. Horm. Metab. Res. 3, 289 (1971).CrossRefGoogle Scholar
  2. 2.
    Fox, I.H., and Kelley, W.N. Metabolism 21, 713 (1972).CrossRefGoogle Scholar
  3. 3.
    Heuckenkamp, P.-U., Zöllner, N. Lancet 1, 808 (1971).CrossRefGoogle Scholar
  4. 4.
    Heuckenkamp, P.-U., Schill, K., Zöllner, N. Verh. dtsch.Ges.inn.Med. 77, 177 (1971).PubMedGoogle Scholar
  5. 5.
    Mäenpää, P.H., Raivio, K.O., and Kekomaki, M.P. Science 161, 1253 (1968).CrossRefGoogle Scholar
  6. 6.
    Perheentupa, J., Raivio, K.O. Lancet II, 528 (1967).CrossRefGoogle Scholar
  7. 7.
    Sperling, O., Eilam, G., Persky-Brosh, S., and DeVries, A. J. Lab. Clin. Med. 79, 1021 (1972).Google Scholar

Copyright information

© Springer Science+Business Media New York 1974

Authors and Affiliations

  1. 1.Medical PolyclinicUniversity of MunichMunich 2Germany

Personalised recommendations